Completed NA INTERVENTIONAL 2-arm NCT03064815

The SpACE Study - Small Bowel Crohn's Disease and Spondyloarthropathies (SpACE)

Prevalence of Small Bowel Inflammatory Crohn's Disease Lesions in Patients With Spondyloarthropathies (SpA): A Prospective Capsule Endoscopy-Based Study

Sponsor: AbbVie

Conditions Crohn Disease Spondyloarthropathy

Interventions Fecal calprotectin PROMETHEUS® IBD sgi Diagnostic™ Videocapsule endoscopy colonoscopy

Updated 7 times since 2017 Last updated: Aug 14, 2019 Started: Jun 30, 2009 Primary completion: Mar 31, 2016 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Crohn Disease and Spondyloarthropathy and is currently completed. AbbVie leads this study, which shows 7 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2019 — Jan 2021 [monthly]

Completed NA
Sep 2019 — Oct 2019 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Sep 2019 [monthly]

Completed NA
Mar 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AbbVie
McGill University Health Centre/Research Institute of the McGill University Health Centre
Prometheus Laboratories

Data source: McGill University Health Centre/Research Institute of the McGill University Health Centre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada